Form 8-K - Current report:
SEC Accession No. 0001585364-25-000010
Filing Date
2025-02-27
Accepted
2025-02-27 17:29:55
Documents
16
Period of Report
2025-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prgo-20250227.htm   iXBRL 8-K 53174
2 EX-99.1 cy24q4ex991pressrelease.htm EX-99.1 1135605
7 perrigoimagenewa.jpg GRAPHIC 18151
  Complete submission text file 0001585364-25-000010.txt   1486327

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20250227.xsd EX-101.SCH 4182
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prgo-20250227_def.xml EX-101.DEF 18402
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20250227_lab.xml EX-101.LAB 34870
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20250227_pre.xml EX-101.PRE 19434
19 EXTRACTED XBRL INSTANCE DOCUMENT prgo-20250227_htm.xml XML 7042
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 25681033
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)